The aim of this study was to assess the outcome of 149 patients with breast cancer and leptonieningeal metastasis (LM) and to compare the efficacy of intrathecal methotrexate and liposomal cytarabine. Among treatment methods, only systemic therapy prolonged survival in these patients. Survival of patients treated intrathecally with methotrexate and those treated with liposomal cytarabine was comparable
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
Background and objective Leptomeningeal carcinomatosis is a rare type of metastatic tumors of the ce...
Objective: To compare the efficacy of intrathecal methotrexate single therapy with three-drug combin...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
BACKGROUND DEPOSEIN (NCT01645839) was a randomized open-label phase III study to explore the role o...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
BACKGROUND DEPOSEIN (NCT01645839) was a randomized open-label phase III study to explore the role o...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
Background and objective Leptomeningeal carcinomatosis is a rare type of metastatic tumors of the ce...
Objective: To compare the efficacy of intrathecal methotrexate single therapy with three-drug combin...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
BACKGROUND DEPOSEIN (NCT01645839) was a randomized open-label phase III study to explore the role o...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and...
BACKGROUND DEPOSEIN (NCT01645839) was a randomized open-label phase III study to explore the role o...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBackground: DEPOSEIN (NCT01645839) was a randomized open-label phase III study...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...
International audienceBACKGROUND: Leptomeningeal metastasis (LM) is a rare complication of metastati...